calendar

4 catalysts · 4 approval

next 91 dayslessmore

MonWedFri

view

sort

Week of Nov 18, 2019

4

Nov 21, 2019approval2455d agoCALQUENCE (ACALABRUTINIB) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

Nov 21, 2019approval2455d agoCALQUENCE (ACALABRUTINIB) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

Nov 21, 2019approval2455d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL

Nov 21, 2019approval2455d agoIMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

Sponsor: PHARMACYCLICS LLC. Form: TABLET. Route: ORAL

$AZN162.35+0.58%

$ABBV245.40-0.26%